Current controversies in urinary tract infections: ICI‐RS 2017. (31st July 2018)

• Record Type: Journal Article
• Authors: Averbeck, Marcio A.; Rantell, Angela; Ford, Abigail; Kirschner‐Hermanns, Ruth; Khullar, Vik; Wagg, Adrian; Cardozo, Linda
• Is Part Of: Neurourology and urodynamics. Volume 37(2018)Supplement 4
• Page Start: S86
• Page End: S92
• Publication Date: 2018-07-31
• Subjects: bacteriuria -- biomarkers -- diagnosis -- treatment -- urinary tract infection; Urinary organs -- Periodicals; Urodynamics -- Periodicals; Urology -- Periodicals; 616.6
• DOI: 10.1002/nau.23563
• Languages: English
• ISSNs: 0733-2467

Abstract

Abstract : Aims: The current definition of urinary tract infection (UTI) relies on laboratory and clinical findings, which may or may not be relevant, depending upon the patient group under consideration. This report considers the utility of current definitions for UTI in adults with and without underlying neurological conditions in order to identify gaps in current understanding and to recommend directions for research. Methods: This is a consensus report of the proceedings of Think Tank TT3: "How do we define and when do we treat UTI in neurological and non‐neurological adult patients?" from the annual International Consultation on Incontinence‐Research Society (ICI‐RS), June 8‐10, 2017 (Bristol, UK). Results: Evidence considering the definitions of UTI in patients with and without neurological diseases was reviewed and synthesized. We examined research on laboratory methods and clinical definitions, focusing on specific cut‐off values for the quantification of significant bacteriuria, and leucocyturia. Several areas were identified, mostly related to the lack of evidence‐based definitions of significant bacteriuria for different patient groups, as well as uncertainties about the role of inflammatory biomarkers, and non‐specific symptoms and signs. Conclusions: One of the biggest challenges in clinical practice is to discriminate between asymptomatic bacteriuria and symptomatic UTI. Future research should concentrate on risk factors for developing symptomatic UTI in different patient groups. Targeted investigations for specific populations, such as the frail elderly, and patients with neurogenic bladder dysfunction, are still needed.